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Background: The rational of thoracic endovascular aortic repair (TEVAR) in patients with type B aortic dissections is exclusion of the portal of 
entry to promote false luminal thrombosis. This study aimed at evaluating the remodeling process of the true lumen (TL) and false lumen (FL) in 
patients undergoing TEVAR Vs medical treatment (MT).
Methods: We retrospectively reviewed the CT scans of 77 patients (62 men, 15 women; mean age: 65 years) using post-processing software to 
analyze volumes of TL and FL. Forty three patients underwent TEVAR while 34 underwent MT. We measured the aortic volumes from LSA origin to 
celiac trunk (V1) and from celiac trunk to the aortic bifurcation (V2). In case of retrograde extension, additional volume (V3) from aortic valve to LSA 
origin was also measured. For each segment, we quantified the changes of the total aortic volume, the TL and FL volumes as well as the enhancing 
and thrombotic components of the FL. Volume changes in V1, V2 and V3 segments were compared for TEVAR and MT.
Results: Before treatment TL V1 and FL V1 were 136±63 and 277±242 ml respectively for TEVAR patients while TL V1 and FL V1 were 127±55 
and 202±168 ml respectively for MT patients. There were no significant difference for the TL and FL between the TEVAR and MT groups at baseline 
(p>0.05). Patients were followed for 36 and 38 months for TEVAR and MT patients. In TEVAR group, TL V1 increased significantly after treatment 
to 175±60 ml, further increase to 247±83 ml was noted in last follow up scan (p<0.001). FL V1 showed overall stability after TEVAR: a significant 
decrease in enhancing component (p<0.001) and significant increase in thrombotic component (p<0.001). For MT group, TL V1 increased to 
162±87 ml (p=0.005). FL V1 showed a non-significant increase (p = 0.5). TL V1 showed an average increase of 81.6% in TEVAR group compared to 
20 % in MT group (P=0.014). There was no significant evolution in V2 and V3 segments.
Conclusion: TEVAR permitted FL stability (Unlike MT) thus preventing aneurismal evolution. Volume measurement is an accurate, reproducible and 
reliable technique. Moreover, it provides morphological data to evaluate global and segmental aortic evolution.
